The value of confirmatory testing in early infant HIV diagnosis programmes in South Africa: A cost-effectiveness analysis
Submitted by susan on Thu, 2017-11-23 14:57
The specificity of nucleic acid amplification tests (NAATs) used for early infant diagnosis (EID) of HIV infection is <100%, leading some HIV-uninfected infants to be incorrectly identified as HIV-infected. The World Health Organization recommends that infants undergo a second NAAT to confirm any positive test result, but implementation is limited. Our objective was to determine the impact and cost-effectiveness of confirmatory HIV testing for EID programmes in South Africa.
Main Topic:
Attachment(s):
Mark Content Private(Internal):
Email Alert:
1-21
Publication Date:
21/11/2017